Mitomycin C Does Not Inhibit Exacerbation of Granular Corneal Dystrophy Type II Induced by Refractive Surface Ablation

Purpose: To evaluate the effect of mitomycin C (MMC) on the exacerbation of corneal opacity that occurs in patients with granular corneal dystrophy type II (GCD II) after refractive corneal surface ablation. Methods: Ten eyes of patients with GCD II who underwent refractive corneal surface ablation with MMC were compared with 10 eyes that were not treated with MMC. Best spectacle-corrected visual acuity, the degree of corneal opacity, and contrast sensitivity were evaluated at least 3 years after surgery. Corneal opacities were quantified using Pentacam densitometry maps. Results: No measured between-group value showed a statistically significant difference. Conclusion: Simultaneous application of MMC does not prevent exacerbation of GCD II after refractive corneal surface ablation.

[1]  Y. Chen,et al.  Correlation of lens density measured using the Pentacam Scheimpflug system with the Lens Opacities Classification System III grading score and visual acuity in age-related nuclear cataract , 2008, British Journal of Ophthalmology.

[2]  H. Lee,et al.  Mitomycin C induces apoptosis in cultured corneal fibroblasts derived from type II granular corneal dystrophy corneas , 2008, Molecular vision.

[3]  Terry Kim,et al.  Comparison of corneal deposits after LASIK and PRK in eyes with granular corneal dystrophy type II. , 2008, Journal of refractive surgery.

[4]  R. D. Stulting,et al.  Exacerbation of granular corneal dystrophy type II (Avellino corneal dystrophy) after LASEK. , 2008, Journal of refractive surgery.

[5]  C. Ki,et al.  Deep Anterior Lamellar Keratoplasty in Korean Patients With Avellino Dystrophy , 2007, Cornea.

[6]  E. K. Kim,et al.  Homozygous Granular Corneal Dystrophy Type II (Avellino Corneal Dystrophy): Natural History and Progression After Treatment , 2007, Cornea.

[7]  H. Cho,et al.  Lysosomal Traffic and Degradation of ßig-h3 Protein , 2007 .

[8]  H. Tchah,et al.  Mitomycin C Inhibits Recurrent Avellino Dystrophy After Phototherapeutic Keratectomy , 2006, Cornea.

[9]  F. Chiambaretta,et al.  Récidive d'une dystrophie de Groenouw de type I après photokératectomie thérapeutique , 2004 .

[10]  B. Dastugue,et al.  [Early recurrence of Groenouw type I corneal dystrophy after phototherapeutic keratectomy. Molecular biology study suggests epithelial genesis]. , 2004, Journal francais d'ophtalmologie.

[11]  R. D. Stulting,et al.  Avellino corneal dystrophy after LASIK. , 2004, Ophthalmology.

[12]  K. Sung,et al.  Apoptosis in keratocytes caused by mitomycin C. , 2003, Investigative ophthalmology & visual science.

[13]  S. Duman,et al.  BIGH3 Gene Analysis in the Differential Diagnosis of Corneal Dystrophies , 2001, Cornea.

[14]  M. Goldberg,et al.  Corneal dystrophies of epithelial genesis: the possible therapeutic use of limbal stem cell transplantation. , 2001, Archives of ophthalmology.

[15]  G. Klintworth.  Advances in the molecular genetics of corneal dystrophies. , 1999, American journal of ophthalmology.

[16]  R. Eagle,et al.  Immunolocalization of beta ig-h3 protein in 5q31-linked corneal dystrophies and normal corneas. , 1999, Archives of ophthalmology.

[17]  R. Folberg,et al.  Avellino corneal dystrophy. Clinical manifestations and natural history. , 1992, Ophthalmology.

[18]  W. Green,et al.  Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. , 1991, Archives of ophthalmology.

[19]  R. Folberg,et al.  Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families. , 1988, Ophthalmology.